Assessment of the Pharmacokinetic-Pharmacodynamic Interaction Between Terazosin and Finasteride

    December 1996 in “ The Journal of Clinical Pharmacology ”
    Emil Samara, Bala Hosmane, Charles Locke … G. Richard Granneman
    Studysummary Terazosin and finasteride together cause no major issues.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on onlinelibrary.wiley.com →
    Discuss this study in the Community →

    Research cited in this study 3

    1. Finasteride, A Steroid 5α-Reductase Inhibitor, Does Not Affect the Oxidative Metabolism of Antipyrine The Journal of Clinical Pharmacology · 1993
    2. Finasteride Drugs · 1993
    3. High-Performance Liquid Chromatographic Method for the Determination of Finasteride in Human Plasma at Therapeutic Doses Journal of Chromatography B: Biomedical Sciences and Applications · 1991

    Related research 3

    1. Saturable Binding of Finasteride to Steroid 5α-Reductase as Determinant of Nonlinear Pharmacokinetics Drug Metabolism and Pharmacokinetics · 2010
    2. A Risk-Benefit Assessment of Treatment with Finasteride in Benign Prostatic Hyperplasia Drug safety · 1998
    3. Assessment of the Pharmacokinetic-Pharmacodynamic Interaction Between Terazosin and Finasteride The Journal of Clinical Pharmacology · 1996